Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
FinanceMoody's Analytics, a leading provider of economic forecasts, expects the current US economic expansion to be one of the longest in history, as jobs continue to grow, wages revive, and households and businesses balance sheets strengthen.
LegalGoing through a divorce can be one of the most challenging experiences in life, and sorting out financial matters can make it even more complicated.
NewsRetailers are operating in one of the most digitally exposed sectors today, and application security has become a frontline concern.
FinanceThe key figure within the recent inflation data was not the headline of the Consumer Price Index (CPI) rate, but instead, the surprise jump in core inflation was an eye opener this time around.
FinanceChina's slowdown in economic growth may have further repercussions for the global economy, the International Monetary Fund has warned.
InnovationSocial media has become a vital part of online business success. All industries nowadays belong equally to the virtual and the real world; through social media, companies can directly interact with customers on several online platforms and form a relationship
LeadershipUnder the Business Elite Awards 2017, the exclusive CEO of the Year - Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to
FinanceDavid joined OBS Logistics, which is a member of the Anisa Group of companies, in 2006.
InnovationThere are exceptional scientists in all fields, and then there are the truly outstanding specialists in their unique fields. Dr Desmer Destang is one such individual, having been highly regarded as one of the finest orthodontic and oro-facial orthopaedic speci
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
